Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Measuring Itch: Chronic Pruritus - Bedside to Bench Perspectives

Description

The presentation by Emily Call, an assistant professor in dermatology, focuses on the complexities of measuring chronic itch, or pruritus, highlighting the significance of both subjective and objective assessment tools. Call emphasizes that accurate measurement of itch is crucial for understanding skin diseases, evaluating treatment effectiveness, and addressing the lived experiences of patients, including impacts on quality of life. She discusses several validated measurement tools, such as the Numeric Rating Scale (NRS), Verbal Rating Scale (VRS), and Visual Analog Scale (VAS), and articulates challenges in their implementation due to the subjective nature of itch which can lead to variability in patient reporting. The presentation also covers the importance of incorporating automated data capture systems, wearable technologies, and biomarkers to enhance the accuracy of itch assessments. Emerging technologies, such as smartphone applications and machine learning for scratch analysis, are seen as promising directions for future developments in itch measurement and treatment customization. Ultimately, Call concludes that multisystem approaches are essential for effectively measuring itch and improving treatment outcomes.

View more

Conclusions

  • Measuring itch is essential for understanding, diagnosing, and monitoring skin disease.
  • Accurate itch assessments facilitate the evaluation of treatment effectiveness.
  • Itch impacts quality of life and mental health, necessitating comprehensive measurement tools.
  • Subjective itch reports can vary widely and may not correlate with objective measures, necessitating a multimodal approach.
  • Validated tools such as NRS, VRS, and VAS are recommended for clinical and research use.
  • Multiple dimensions of itch, including physical and psychological effects, should be assessed for effective treatment planning.
  • Emerging technology and automated data capture may significantly enhance the precision of itch measurement.
  • Personalized biomarkers may provide targeted therapy opportunities in managing itch.
  • There is a need for collaboration across institutions to improve itch measurement and treatment outcomes.
  • Reich A et al. Tailoring the Cut-Off Values of the Visual Analogue Scale and Numeric Rating Scale in Itch Assessment. Acta Derm Venereol. 2017 Jun 9;97(6):759-760. doi: 10.2340/00015555-2642.
  • Kiimball AB et al. Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis. Br J Dermatol. 2016 Jul;175(1):157-62. doi: 10.1111/bjd.14464.
  • Reich A et al. Itch Assessment with Visual Analogue Scale and Numerical Rating Scale: Determination of Minimal Clinically Important Difference in Chronic Itch. Acta Derm Venereol. 2016 Nov 2;96(7):978-980. doi: 10.2340/00015555-2433.
  • Simpson EL et al. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020.
  • Finlay AY and GK Khan. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994 May;19(3):210-6. doi: 10.1111/j.1365-2230.1994.tb01167.x.
  • Desai NS et al. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol. 2008 Aug;59(2):234-44. doi: 10.1016/j.jaad.2008.04.006.
  • Love EM et al. ItchyQoL bands: pilot clinical interpretation of scores. Acta Derm Venereol. 2015 Jan;95(1):114-5. doi: 10.2340/00015555-1891.
  • Walia HK and Mehra R. Practical aspects of actigraphy and approaches in clinical and research domains. Handbook of Clinical Neurology 2019;160:371-379.
  • Mochizuki H et al. What does brain imaging tell us about itch? Itch 4(1):p e23, March 2019. doi: 10.1097/itx.0000000000000023.
  • Mochizuki H and Kakigi R. Central Mechanisms of Itch. Clinical Neurophysiology 2014; 126(9). International Federation of Clinical Neurophysiology.